Aug 19, 2025 • Benzinga
SOMEWHAT-BULLISH
This Thermo Fisher Scientific Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - AeroVironment ( NASDAQ:AVAV ) , Celestica ( NYSE:CLS )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Aug 07, 2025 • Motley Fool
NEUTRAL
Nuvalent ( NUVL ) Q2 R&D Up 65%
Nuvalent ( NASDAQ:NUVL ) , a clinical-stage biotechnology company developing therapies for cancers driven by kinase mutations, released its second quarter 2025 earnings results on August 7, 2025. There was no product revenue, consistent with expectations for a pre-commercial biotech.
Jun 24, 2025 • Benzinga
NEUTRAL
Nuvalent Touts 'Positive' Data From Lung Cancer Drug Trial - Nuvalent ( NASDAQ:NUVL )
Zidesamtinib achieves a 51% ORR and 93% 12- and 18-month durability in patients with one prior ROS1 TKI. Intracranial ORR is 85% in patients previously treated with crizotinib, including 54% complete responses.
Feb 24, 2025 • GlobeNewswire
SOMEWHAT-BULLISH
Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer
WELLESLEY HILLS, Mass., Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- Climb Bio, Inc. ( Nasdaq: CLYM ) announced today the appointment of Perrin Wilson, Ph.D. as Chief Business Officer. Dr. Wilson is an accomplished leader, with over 17 years of experience in the pharmaceutical and biotech industry.
Feb 24, 2025 • Benzinga
SOMEWHAT-BULLISH
Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer - Climb Bio ( NASDAQ:CLYM )
WELLESLEY HILLS, Mass., Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- Climb Bio, Inc. CLYM announced today the appointment of Perrin Wilson, Ph.D. as Chief Business Officer. Dr. Wilson is an accomplished leader, with over 17 years of experience in the pharmaceutical and biotech industry.
Dec 30, 2024 • Benzinga
SOMEWHAT-BULLISH
This Nuvalent Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Arcutis Biotherapeutics ( NASDAQ:ARQT ) , Artiva Biotherapeutics ( NASDAQ:ARTV )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. HC Wainwright & Co. analyst Ed Arce initiated coverage on MetaVia MTVA with a Buy rating and announced a ...